Registration Fee:

NPA Members - Free
Non-Members - $25

Learning Outcome:
There is a need for advanced practice nurses to increase their knowledge and skills regarding the latest evidence for understanding pain management and opioids and to apply that information to their practices to improve their patient outcomes. This newly updated course is designed to meet the FDA’s Opioid Analgesic REMS.

CO*RE Case-Based Curriculum: CO*RE Case-Based Curriculum: Our case-based session delivers a real-world educational experience through a series of cases and supporting content mapped to segments of the FDA Blueprint. This allows faculty to teach application of concepts, fostering an engaging approach to pain management education.

BY THE END OF THIS SESSION, THE LEARNER WILL BE ABLE TO:
- Recognize the origin(s) and types of pain as they relate to pain management and opioid use disorder (OUD)
- Fully assess persons experiencing pain, including risk for OUD
- Develop safe and effective pain management plans using nonpharmacologic and pharmacologic (non-opioid or opioid) options
- Partner with patients to reduce risks when taking opioid therapy
Supplemental education also available includes modules on telehealth, addressing cannabis, fentanyl, stigma, health inequities/social determinants, and surgical education; a pocket-ready guide; a podcast series; and numerous brief teaching videos.

This program meets many states’ requirements for opioid education and is fully compliant with the Opioid Analgesic Risk Evaluation and Mitigation Strategy (REMS) education requirement (“Blueprint”), issued by the U.S. Food & Drug Administration in October 2023. As of June 27, 2023, DEA registrants are to have completed a total of at least 8 hours of training on opioid or other substance use disorders.

The curriculum was developed by the Collaborative for REMS Education (CO*RE) http://core-rems.org and is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies (RPC).

This course meets the criteria outlined by Substance Abuse and Mental Health Services Administration (SAMHSA) to count toward DEA required training. The Access and Training Expansion (MATE) Act requires new or renewing Drug Enforcement Agency (DEA) registrants, as of June 27, 2023, to have completed a total of at least eight hours of training on opioid or other substance use disorders.


Contact Information:
Presented by Nurse Practitioner Healthcare Foundation, a member of the Collaborative on REMS Education (CO*RE), ten interdisciplinary organizations working together to improve pain management and prevent adverse outcomes, including AAFP, AANP, AAPA, AAHPM, AOA, ASAM, CAFP, IPMA, NPHF & AAOS. For more information, please contact NPHF or visit www.core-rems.org.

Speaker Information: Wendy Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP

Wendy received her Doctor of Nursing Practice in 2019 from the University of Alabama, Tuscaloosa. She is a 1992 graduate of the Adult Primary Care Nurse Practitioner program at Simmons College in Boston and completed a family nurse practitioner post-master’s program in 1995. She is an adult and family nurse practitioner and the owner of two nurse practitioner-owned and -operated clinics within New Hampshire named Wright & Associates Family Healthcare. Her family practices have won numerous awards, including Top Providers in New Hampshire 2018, Top 20 Fastest Growing Family Business, and Top 20 Women-Owned Business in New Hampshire. In addition, she is the Owner of Partners in Healthcare Education, a medical education company. She is the Past President of NPACE and the Senior lecturer for Fitzgerald Health Education Associates.

She is the recipient of numerous awards and was chosen by the American Association of Nurse Practitioners as the 1999 recipient of the New Hampshire State Excellence Award. In addition, she received the 2009 New Hampshire Nurse Practitioner of the Year and the 2014 Top 5 Women in New Hampshire Business Award. In 2005, she was inducted as a Fellow into the American Academy of Nurse Practitioners; in October 2014, a Fellow in the American Academy of Nursing; and in March 2017, a Fellow into the National Academies of Practice.

She is the founder of the New Hampshire Chamber of Entrepreneurial Nurse Practitioners, an organization designed to assist nurse practitioners with independent practice issues. In addition to full-time clinical practice, she presents nationally to different audiences and has been a speaker at over 1,000 conferences in 47 states. She is the nurse practitioner representative to the State of New Hampshire Immunization Advisory Board. She has been a medical media spokesperson for numerous companies and has appeared on radio, television, and in print magazines. Wendy is frequently consulted by malpractice attorneys around the area of clinical practice and has worked on more than 100 malpractice cases involving nurses and nurse practitioners.

CE for Nurses/Nurse Practitioners:

Accreditation Statement
The Nurse Practitioner Healthcare Foundation (NPHF) is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. NPHF is awarding the contact hours and is responsible for adherence to the ANCC criteria. This learning activity is presented in partnership with the CO*RE Collaborative.

Criteria for Awarding Contact Hours
This course provides 2.00 contact hours including 2.00 pharmacology hours. Criteria for awarding the contact hour includes completion of the course, evaluation and post-test.

Accredited Provider Disclosure
As a provider dedicated to independent education and accredited by the ANCC,
NPHF must ensure balance, independence, objectivity, and scientific rigor in all its
educational activities. All individuals with the ability to influence the content of this educational activity reported the following: none of the faculty advisors, reviewers or planners for this educational activity have relevant financial relationships with ineligible companies to disclose.
Wendy Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP, faculty for this educational event, is on the speaker bureau is a consultant for GSK. Relevant financial relationships have been mitigated.

Commercial Support:
This educational activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies (RPC). Please see www.er-la-opioidREMS.com for a listing of the member companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the US Food & Drug Administration (FDA).